| Autor: |
Nogueira de Brito, Raíssa, Passarella Teixeira, Ana Izabel, Carvalho Gontijo, Carolina, Da Silva Faria, Rafael, Massa Ramalho, Walter, Sierra Romero, Gustavo Adolfo, Castro, Manoel, Pessoa, Vitoria, Araújo Torres, Larissa, Pereira Leite, Larissa, Ferreira Noronha, Elza, Haddad, Rodrigo, Navegantes de Araújo, Wildo |
| Předmět: |
|
| Zdroj: |
Vaccines; May2023, Vol. 11 Issue 5, p916, 14p |
| Abstrakt: |
Estimating seroprevalence and vaccination coverage against COVID-19 is crucial to the development of well-targeted public health policies at the local level. Here, we estimated seroprevalence and vaccination coverage in a lower-middle-class population in Brazil. We conducted an observational, cross-sectional, population-based survey from 24 September to 19 December 2021. CMIA tests were used to detect anti-SARS-CoV-2 IgG against the N-protein. The overall seroprevalence was 24.15% (177/733), and vaccination coverage was 91.40% (670/733); 72.09% (483/670) were fully vaccinated. Among vaccinated participants, seroprevalence was 24.77% (95% CI 21.50–28.04; 166/670), with a prevalence ratio (PR) of 1.03 (95% CI 0.98–1.08; p-value 0.131). Among participants who received an mRNA vaccine with S-based epitope (485), seroprevalence was 16.29% (95% CI 13.04–19.85; 79/485). Among unvaccinated participants, seroprevalence was 17.46% (95% CI 10.04–28.62; 11/63). Finally, in spite of the political climate and other possible causes for vaccine hesitancy, the positive Brazilian culture towards vaccination might have curbed hesitancy. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
